Literature DB >> 6127595

Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers.

B Rapoport, S Filetti, N Takai, P Seto, G Halverson.   

Abstract

Studies were conducted on the cultured human thyroid cell bioassay for thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH). In confirmation of the data of Kasagi, et al.,15 incubation of human thyroid cells in Hank's balanced salt solution deficient in NaCl increased the sensitivity of the c-AMP response to bovine TSH by approximately one order of magnitude. Half-maximal stimulation was attained at approximately 0.1 mU bTSH/ml. The effect of NaCl in the medium was greater with stimulation by TSI greater than hTSH greater than bTSH. In contract to incubations in NaCl(+)medium, with NaCl(-) medium most (70%-80%) of the c-AMP produced was released into the medium; this proportion remaining relatively constant over a wide range of bTSH and hTSH concentrations. At TSI concentrations higher than 3mg/ml efflux of c-AMP into the medium was significantly diminished. Stimulation by cholera toxin and prostaglandin E of thyroid cell c-AMP generation was not enhanced in NaCl(-) medium, in contrast to stimulation by TSH and TSI. The presence of 10(-4)m cycloheximide in NaCl(+) medium enhanced the c-AMP response to physiological concentrations of TSH. As with NaCl(-) medium, cycloheximide increased the sensitivity but not the maximum response of the c-AMP response to TSH. However no additivity was observed with NaCl(-) medium and cycloheximide. Human thyroid cells obtained from patients with Graves' disease are relatively insensitive to TSI stimulation. In NaCl(-) medium, however, the sensitivity of these cells to TSI stimulation is sufficient to enable them to be utilized in the TSI assay. The present state of the TSI assay is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127595     DOI: 10.1016/0026-0495(82)90168-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.

Authors:  F Vermiglio; S Benvenga; R Melluso; S Catalfamo; P Princi; S Battiato; F Consolo; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

2.  Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.

Authors:  R C Williams; N J Marshall; K Kilpatrick; J Montano; P M Brickell; M Goodall; P A Ealey; B Shine; A P Weetman; R K Craig
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

3.  Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.

Authors:  E Laurent; J Van Sande; M Ludgate; B Corvilain; P Rocmans; J E Dumont; J Mockel
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

4.  Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.

Authors:  Y Nagayama; H L Wadsworth; D Russo; G D Chazenbalk; B Rapoport
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Interleukin-21 is associated with disease activity in patients with Graves' disease.

Authors:  Jin Zhang; Hua Zeng; Meng Ren; Haiyan Yan; Mingtong Xu; Zhimei Feng; Weiwen Liang; Chuan Yang; Hua Cheng; Helin Ding; Li Yan
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

6.  Rabbits immunized with thyroid-stimulating hormone produce autoantiidiotypic thyroid-stimulating antibodies.

Authors:  G N Beall; B Rapoport; I J Chopra; S R Kruger
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

7.  Monoamine oxidase activity and triiodothyronine biosynthesis in human cultured thyroid cells.

Authors:  Z Kraiem; O Sadeh; M B Youdim
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

8.  Autoantibody stimulation of the human thyrotropin receptor: regulation of adenylate cyclase activity, thyroglobulin and thyroid peroxidase mRNA levels in primary cultures of Graves' thyroid tissue.

Authors:  K S Collison; J P Banga; P S Barnett; G C Huang; A M McGregor
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.

Authors:  M Zakarija; A Garcia; J M McKenzie
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

10.  Thyrotropin binding specificity for the thyrotropin receptor.

Authors:  Y Nagayama; H Yamasaki; A Takeshita; H Kimura; K Ashizawa; N Yokoyama; S Yamashita; B Rapoport; S Nagataki
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.